AYTU BIOPHARMA, INC
For the period ended Dec 31, 2025. Filed Feb 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2025 · Filed Feb 3, 2026
AYTU$1.79-2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
AYTU BIOPHARMA, INC.
FORM 10-Q
TABLE OF CONTENTS
| Page | ||
|---|---|---|
| Cautionary Information Regarding Forward-Looking Statements | 3 | |
| PART I - FINANCIAL INFORMATION | 4 | |
| Item 1. | Financial Statements | 4 |
| Unaudited Consolidated Balance Sheets | 4 | |
| Unaudited Consolidated Statements of Operations | 5 | |
| Unaudited Consolidated Statements of Stockholders’ Equity | 6 | |
| Unaudited Consolidated Statements of Cash Flows | 7 | |
| Notes to the Unaudited Consolidated Financial Statements | 8 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 31 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 38 |
| Item 4. | Controls and Procedures | 38 |
| PART II - OTHER INFORMATION | 39 | |
| Item 1. | Legal Proceedings | 39 |
| Item 1A. | Risk Factors | 39 |
| Item 5. | Other Information | 39 |
| Item 6. | Exhibits | 39 |
| SIGNATURES | 40 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.